Howard W. Robin, President & CEO at NEKTAR THERAPEUTICS (NKTR), sold 1,500 shares at $30.16 ($45K) on 2025-09-02, disclosed to the SEC on 2025-09-04.
Scheduled sale ($45k) by President & CEO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| NKTR | SELL | 2026-05-21 | $29K | — | Filing → |
| NKTR | SELL | 2026-02-20 | $31K | — | Filing → |
| NKTR | SELL | 2025-11-25 | $240K | — | Filing → |